Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.46Price to Sales
VS
Market
Sector
Industry
History
$ 2.75Close
$ 0.73 - $ 3.83 52-Week Range
Ticker Information
Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQESPERION THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESPR - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 391.15M | 1.46 | $ 268.13M |
| 3/31/2025 | $ 176.99M | 0.68 | $ 259.57M |
| 12/31/2024 | $ 334.36M | 1.01 | $ 332.31M |
| 9/30/2024 | $ 415.74M | 1.41 | $ 295.45M |
| 6/30/2024 | $ 361.05M | 1.3 | $ 277.79M |
| 3/31/2024 | $ 449.02M | 1.95 | $ 229.74M |
| 12/31/2023 | $ 536.65M | 4.61 | $ 116.33M |
| 9/30/2023 | $ 117.13M | 1.14 | $ 102.9M |
| 6/30/2023 | $ 180.82M | 2.06 | $ 87.91M |
| 3/31/2023 | $ 134.49M | 1.66 | $ 80.97M |
Key Performance Insights, Last 5 Years
- ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 3.69.
- Over the past 5 years, ESPERION THERAPEUTICS INC's average P/S has been 3.31.
- The median P/S for ESPERION THERAPEUTICS INC during this period was 3.26
- ESPERION THERAPEUTICS INC reached its highest P/S over the past 5 years at 8.47.
- The lowest P/S recorded by ESPERION THERAPEUTICS INC in the same timeframe 0.68
ESPERION THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ESPERION THERAPEUTICS INC is calculated as follows: Market Cap [ $ 808.14M ] / Revenues [ $ 218.89M ]
(=) P/S [ 3.69 ] ESPR - Price to Sales, Last 5 years
0.68
Minimum
Mar 31, 2025
8.47
Maximum
Sep 30, 2022
3.31
Average
3.26
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |